Article ; Online: Chronic myeloid leukaemia and the use of tyrosine kinase inhibitors in the days of COVID-19 pandemic.
British journal of clinical pharmacology
2020 Volume 86, Issue 9, Page(s) 1790–1792
MeSH term(s) | Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Antiviral Agents/adverse effects ; Antiviral Agents/therapeutic use ; COVID-19 ; Drug Interactions ; Humans ; Imatinib Mesylate/adverse effects ; Imatinib Mesylate/therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy ; Pandemics ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/therapeutic use ; Protein-Tyrosine Kinases/antagonists & inhibitors |
---|---|
Chemical Substances | Antineoplastic Agents ; Antiviral Agents ; Protein Kinase Inhibitors ; Imatinib Mesylate (8A1O1M485B) ; Protein-Tyrosine Kinases (EC 2.7.10.1) |
Keywords | covid19 |
Language | English |
Publishing date | 2020-05-20 |
Publishing country | England |
Document type | Editorial |
ZDB-ID | 188974-6 |
ISSN | 1365-2125 ; 0306-5251 ; 0264-3774 |
ISSN (online) | 1365-2125 |
ISSN | 0306-5251 ; 0264-3774 |
DOI | 10.1111/bcp.14353 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1118: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.